Induction of blood lymphocyte cytochrome P450 2E1 in early stage alcoholic liver cirrhosis

Alcohol

Volumn 45, Issue 1, 2011, Pages 81-87

  Khan, Anwar Jamal ^a   Sharma, Amit ^a   Choudhuri, Gourdas ^b   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alcoholic; Cirrhosis; CYP2E1; Lymphocyte; NDMA d; Toxicity

Indexed keywords

ALCOHOL; CYTOCHROME P450 2E1; DIMETHYLNITROSAMINE DEMETHYLASE; MESSENGER RNA;

ADULT; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INDIA; LIVER CIRRHOSIS; LYMPHOCYTE; PREDICTION; PROTEIN EXPRESSION;

ADULT; ALCOHOLISM; CYTOCHROME P-450 CYP2E1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LYMPHOCYTES; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78650582973     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2010.08.007     Document Type: Article

References (43)

1. Agundez J., Ladero M., Rubio D., Benitez J. Rsa I polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol-related severe liver disease. Liver 1996, 16:380-383.
2. Albano E., Clot P., Morimoto M., Tomasi Ingelman-Sundberg M., French S. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radicals in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 1996, 23:155-163.
3. Albano E., Tomasi A., Persson J.O., Terelius Y., Goria-Gatti L., Ingelman-Sundberg M., et al. Role of ethanol-inducible cytochrome P-450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. 1991, 41:1895-1902.
4. Amet Y., Berthou F., Fournier G., Dreano Y., Bardou L., Cledes J., et al. Cytochrome P450 4A and 2E1 expression in human kidney microsomes. Biochem. Pharmacol. 1997, 53:765-771.
5. Badger T.M., Ronis M.J., Seitz H.K., Albano E., Ingelman-Sundberg M., Lieber C.S. Alcohol metabolism, role in toxicity and carcinogenesis. Alcohol. Clin. Exp. Res. 2003, 27:336-347.
6. Bastien M.C., Leblond F., Pichette V., Villeneuve J.P. Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can. J. Physiol. Pharmacol. 2000, 78:912-919.
7. Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 1968, 21:77-90.
8. Dey A., Dhawan A., Seth P.K., Parmar D. Evidence for cytochrome P450 2E1 catalytic activity and expression in rat blood lymphocytes. Life Sci. 2005, 77:1082-1093.
9. Dey A., Parmar D., Dayal M., Dhawan A., Seth P.K. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes evidence for catalytic activity and mRNA expression. Life Sci. 2001, 69:383-393.
10. Dey A., Parmar D., Dhawan A., Dash D., Seth P.K. Cytochrome P450 2E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes. Life Sci. 2002, 71:2509-2519.
11. Dilger K., Metzler J., Bode J.C., Klotz U. CYP2El activity in patients with alcoholic liver disease. J. Hepatol. 1997, 27:1009-1014.
12. Dupont I., Lucas D., Clot P., Ménez C., Albano E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J. Hepatol. 1998, 28:564-571.
13. Ewing J.A. Detecting alcoholism: the CAGE questionnaire. J. Am. Med. Assoc. 1984, 252:1905-1907.
14. George J., Murray M., Byth K., Farrell G.C. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995, 21:120-128.
15. Gochee P.A., Jonsson J.R., Clouston A.D., Pandeya N., Purdie D.M., Powell E.E. Steatosis in chronic hepatitis C, association with increased messenger RNA expression of collagen I tumor necrosis factor-alpha and cytochrome P4502E1. J. Gastroenterol. Hepatol. 2003, 18:386-392.
16. Grove J., Brown A.S., Daly A.K., Bassendine M.F., James O.F., Day C.P. The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians, effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 1998, 8:335-342.
17. Hakkola J., Pasanen M., Purkunen R., Saarikoski S., Pelkonen O., Mäenpää J., et al. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol. 1994, 48:59-64.
18. Haufroid V., Ligocka D., Buysschaert M., Horsmans Y., Lison D. Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes, evaluation in hepatitis C and diabetes. Eur. J. Clin. Pharmacol. 2003, 59:29-33.
19. Haufroid V., Ligocka D., Wallemacq P., Lison D., Horsmans Y. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C. Toxicol. Lett. 2005, 155:171-177.
20. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 1991, 110:559-565.
21. Jones B.E., Liu H., Lo C.R., Koop D.R., Czaja M.J. Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxid. Redox Signal. 2002, 4:701-709.
22. Kapoor N., Pant A.B., Dhawan A., Dwievedi U.N., Gupta Y.K., Seth P.K., et al. Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol. Life Sci. 2006, 79:1514-1522.
23. Lieber C.S. Hepatic metabolic and toxic effects of ethanol, 1991 update. Alcohol. Clin. Exp. Res. 1991, 15:573-592.
24. Lieber C.S. Cytochrome P4502E1, its physiological and pathological role. Physiol. Rev. 1997, 77:517-544.
25. Lieber C.S. Microsomal ethanol-oxidizing system (MEOS), the first 30 years (1968-1998)-a review. Alcohol. Clin. Exp. Res. 1999, 23:991-1007.
26. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 1951, 193:265-275.
27. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemistry 1953, 55:416-421.
28. Novak R.F., Woodcroft K.J. The alcohol-inducible form of cytochrome P450 (CYP2E1), role in toxicology and regulation of expression. Arch. Pharm. Res. 2000, 23:267-282.
29. Powell H., Kitteringham N.R., Pirmohamed M., Smith D.A., Park B.K. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 1998, 8:411-421.
30. Raucy J.L., Curley G., Carpenter S.P. The use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic CYP2E1. Alcohol. Clin. Exp. Res. 1995, 19:1369-1375.
31. Raucy J.L., Kraner J.C., Lasker J.M. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 1993, 23:1-20.
32. Raucy J.L., Schultz E.D., Kearins M.C., Arora S., Johnston D.E., Omdahl J.L., et al. CYP2E1 expression in human lymphocytes from various ethnic populations. Alcohol. Clin. Exp. Res. 1999, 23:1868-1874.
33. Raucy J.L., Schultz E.D., Wester M.R., Arora S., Johnston D.E., Omdahl J.L., et al. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug. Metab. Dispos. 1997, 25:1429-1435.
34. Rodríguez-Antona C., Donato M.T., Pareja E., Gómez-Lechón M.J., Castell J.V. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch. Biochem. Biophys. 2001, 393:308-315.
35. Ronis M.J.J., Lindros K.O., Ingelman-Sundberg M. The CYP2E1 Subfamily in Cytochromes P450. Metabolic and Toxicological Aspects 1996, CRC Press, Boca Raton, FL, pp. 211-239.
36. Savolainen V.T., Pajarinen J., Perola M., Penttila A., Karhunen P.J. Polymorphism in the cytochrome p4502E1 gene and risk of alcoholic liver disease. J. Hepatol. 1997, 26:55-61.
37. Song B.J., Veech R.L., Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin dependent diabetics. J. Clin. Endocr. Metabol. 1990, 71:1036-1040.
38. Spivey J.R., Bronk S.F., Gores G.J. Glycochenodeoxycholate induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J. Clin. Invest. 1993, 92:17-24.
39. Stickel F., Osterreicher C.H. The role of genetic polymorphism in alcoholic liver disease. Alcohol Alcohol. 2006, 41:209-224.
40. Sumida A., Kinoshita K., Fukuda T., Matsuda H., Yamamoto I., Inaba T., et al. Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver. Biochem. Biophys. Res. Commun. 1999, 262:499-503.
41. Vidal F., Lorenzo A., Auguet T., Olona M., Broch M., Gutierrez C., et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men, lack of association with alcoholism and alcoholic liver disease. J. Hepatol. 2004, 41:744-750.
42. Yadav S., Dhawan A., Singh R.L., Seth P.K., Parmar D. Expression of constitutive and inducible cytochrome P450 2E1 in rat brain. Mol. Cell. Biochem. 2006, 286:171-180.
43. Yano H., Tsutsumi M., Fukura M., Chen W.B., Shimanaka K., Tsuchishima M., et al. Study of cytochrome P4502E1 mRNA level of mononuclear cells in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res. 2001, 25:2S-6S.